A new deep learning model combining dermoscopic images with patient metadata achieves 94.5% accuracy in melanoma detection.
Key Details
- 1AI model integrates dermoscopic images and patient data (age, gender, lesion site) for diagnosis.
- 2Achieved 94.5% accuracy and an F1-score of 0.94 using the SIIM-ISIC dataset of over 33,000 images.
- 3Outperformed popular image-only AI models like ResNet-50 and EfficientNet.
- 4Feature analysis showed lesion size, age, and site significantly impact diagnostic accuracy.
- 5Model developed by international team led by Incheon National University; to be published in Information Fusion (Dec 2025).
- 6Potential applications include smartphone-based diagnosis, telemedicine, and AI-assisted dermatology clinics.
Why It Matters
This study demonstrates the value of multimodal AI in diagnostic imaging, highlighting better performance and transparency in early skin cancer detection. Such advances can inform future imaging-AI integration strategies, with implications for clinical workflow and patient care in dermatology and radiology.
Source
EurekAlert
Related News
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.